...
首页> 外文期刊>Research in Veterinary Science >Evaluation of clinical safety and anthelmintic efficacy of aurixazole administed orally at 24 mg/kg in cattle
【24h】

Evaluation of clinical safety and anthelmintic efficacy of aurixazole administed orally at 24 mg/kg in cattle

机译:牛口服24mg / kg奥里唑的临床安全性和驱虫药效果评估

获取原文
获取原文并翻译 | 示例
           

摘要

The current study evaluated, in vivo, the clinical safety and the anthelmintic efficacy of 24% aurixazole (24 mg/kg), administered orally, in bovines. Two experiments were conducted: the first one evaluating the clinical safety of 24% aurixazole (24 mg/kg) in cattle, and a second one evaluating the anthelmintic efficacy of aurixazole (24 mg/kg) against gastrointestinal nematodes on naturally infected cattle. Based on the results of clinical safety, no alterations on clinical and haematological signs and on the biochemical values obtained in animals treated orally with aurixazole 24 mg/kg were observed. Regarding the results of reduction or efficacy, obtained by eggs per gram of faeces (EPG) counts, the formulation of aurixazole reached values superior to 99% (arithmetic means) in all post-treatment dates. In two occasions, this formulation reached maximum efficacy (100%). Comparing these results with the reduction percentages obtained by EPG counts, it is possible to verify that the values obtained by all three formulations were compatible with the efficacy results. Aurixazole reached maximum efficacy (100%) against Haemonchus placei, Cooperia spatulata and Oesophagostomum radiatum. Against Cooperia punctata, this formulation reached an efficacy index of 99.99%. Regarding aurixazole, no specific trials were conducted on the field in order to evaluate the behaviour of this molecule against helminths that are resistant to other molecules, specially isolated levamisole and disophenolat: Due to this fact, future studies will be necessary to assess the effectiveness of aurixazole against strains of nematodes that are resistant to levamisole and disophenolat, but the results of clinical safety and efficacy described in this study allow us to conclude that the aurixazole molecule, concomitantly with other measures and orally administered formulations, can be another important tool in the control of nematodes parasitizing bovines
机译:当前的研究在体内评估了牛口服24%aurixazole(24 mg / kg)的临床安全性和驱虫效果。进行了两个实验:第一个评估牛中24%aurixazole(24 mg / kg)的临床安全性,第二个评估奥利唑(24 mg / kg)对天然感染牛胃肠道线虫的驱虫效力。根据临床安全性的结果,未观察到口服24mg / kg澳沙唑治疗的动物的临床和血液学体征以及生化值发生变化。关于通过鸡蛋/克粪便(EPG)计数获得的降低或功效的结果,在所有治疗后的日期中,aurixazole的配方均达到了优于99%(算术平均值)的值。在两种情况下,该制剂均达到最大功效(100%)。将这些结果与通过EPG计数获得的减少百分比进行比较,可以验证所有三种配方获得的值均与功效结果相符。 Aurixazole对抗Haemonchus placei,Cooperia spatulata和Oesophagostomum radiatum的最大功效(100%)。对抗库珀(Cooperia punctata),该制剂的功效指数达到99.99%。关于aurixazole,在该领域未进行任何具体试验来评估该分子对抵抗其他分子(特别是分离的左旋咪唑和双酚)的蠕虫的行为:由于这个事实,因此有必要进行进一步的研究以评估该药物的有效性。奥利唑抗线虫菌株对左旋咪唑和二酚具有抗药性,但本研究中描述的临床安全性和有效性结果使我们得出结论,奥利唑分子与其他措施和口服制剂一起,可能是该药物中的另一个重要工具控制线虫寄生牛

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号